Frontiers in endocrinology · 2025
GBDKVA score: a scoring system for preoperative risk assessment of adrenal tumors ≤6cm.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Siwei, Yang Xianrui, Yao Zhili, Guo Qi, Hou Zekai, Wang Chenyu, Cui Ronghao, Wang Zhun, Li Gang, Quan Changyi, Niu Yuanjie, Zhao Yan, Kang Shaosan, Cai Qiliang
Аннотация
OBJECTIVES: To propose a comprehensive scoring system for adrenal tumors ≤ 6cm and evaluate its rationality and validity.
MATERIALS AND METHODS: This study retrospectively analyzed 268 patients with primary adrenal tumors who underwent laparoscopic surgery from January 2018 to December 2022 and all of them met the inclusion criteria. Evaluation scores were calculated for gender (G), body mass index (BMI) (B), tumor diameter (D), the relative position of the tumor to the kidney (K), the relative position of the tumor and the blood vessels (V) and the tumor location in the adrenal gland (A). Then, the total scores were correlated with the operation results, so as to verify the feasibility of GBDKVA in evaluating the surgical risk.
RESULTS: The GBDKVA score showed a consistent and statistically significant correlation with operation time (OT) and blood loss (BL), as well as a correlation with postoperative complications in patients (p < 0.01), but no significant correlation was found with recovery time of gastrointestinal function, bed rest days, indwelling drainage tube days and postoperative hospitalization time were opposite.
CONCLUSIONS: GBDKVA score is reliable for preoperative risk assessment of patients with adrenal tumors ≤6cm.
MATERIALS AND METHODS: This study retrospectively analyzed 268 patients with primary adrenal tumors who underwent laparoscopic surgery from January 2018 to December 2022 and all of them met the inclusion criteria. Evaluation scores were calculated for gender (G), body mass index (BMI) (B), tumor diameter (D), the relative position of the tumor to the kidney (K), the relative position of the tumor and the blood vessels (V) and the tumor location in the adrenal gland (A). Then, the total scores were correlated with the operation results, so as to verify the feasibility of GBDKVA in evaluating the surgical risk.
RESULTS: The GBDKVA score showed a consistent and statistically significant correlation with operation time (OT) and blood loss (BL), as well as a correlation with postoperative complications in patients (p < 0.01), but no significant correlation was found with recovery time of gastrointestinal function, bed rest days, indwelling drainage tube days and postoperative hospitalization time were opposite.
CONCLUSIONS: GBDKVA score is reliable for preoperative risk assessment of patients with adrenal tumors ≤6cm.